World Health Organization to Review International Cannabis Laws This Week | CashCropToday
0 Shares 720 Views

World Health Organization to Review International Cannabis Laws This Week

June 4, 2018
720 Views

The World Health Organization (WHO) will examine international cannabis laws this week during the 40th meeting of the Expert Committee on Drug Dependence. WHO called the specially convened sessions in Geneva, Switzerland to review the medicinal benefits of cannabis and cannabis related substances including: the cannabis plant and cananbis resin, extracts and tinctures of cannabis, Delta-9-tetrahydrocannabinol (THC), and Isomers of THC.

The World Health Organization declared that Cannabidiol (CBD), a cannabinoid that can be derived from cannabis and industrial hemp, is non-addictive and contains a number of medicinal applications including the treatment of diseases such as epilepsy. Now the international agency is taking a long look at the cannabis plant as a whole, including its psychoactive component THC.

A number of countries and U.S. states have recently approved the recreational and medicinal uses of cannabis and the pre-preview documents being reviewed by the committee contains a complete breakdown based on pharmacology, toxicology, m and the therapeutic uses of the plant.

If the committee accepts the pre-review, WHO could order a comprehensive and complete examination of the medicinal benefits of the cannabis plant. In turn this could eventually lead to Who changing international cannabis laws.

You may be interested

Cash Crop Today Interview with David Boissinot from Trimpro
Market Watch
3 views
Market Watch
3 views

Cash Crop Today Interview with David Boissinot from Trimpro

Editor - October 23, 2018

Trimpro developes and manufactures top of the line, full service, trimming machines in Canada which can be shipped to growers throughout the world. The following is a…

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX
Market Watch
20 views
Market Watch
20 views

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX

Jaelynn Offerman - October 22, 2018

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages
Global
11 views
Global
11 views

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages

Jaelynn Offerman - October 22, 2018

Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: